BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 947860)

  • 1. Tube leukocyte adherence inhibition assay for the detection of anti-tumour immunity. II. Monocyte reacts with tumour antigen via cytophilic anti-tumour antibody.
    Marti JH; Grosser N; Thomson DM
    Int J Cancer; 1976 Jul; 18(1):48-57. PubMed ID: 947860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tube leukocyte (monocyte) adherence inhibition assay for the detection of anti-tumour immunity. III. "Blockade" of monocyte reactivity by excess free antigen and immune complexes in advanced cancer patients.
    Grosser N; Thompson DM
    Int J Cancer; 1976 Jul; 18(1):58-66. PubMed ID: 59711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tube leukocyte adherence inhibition assay for the detection of anti-tumor immunity. I. Monocyte is the reactive cell.
    Grosser N; Marti JH; Proctor JW; Thomson DM
    Int J Cancer; 1976 Jul; 18(1):39-47. PubMed ID: 1084863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview: antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition.
    Flores M; Marti JH; Grosser N; MacFarlane JK; Thomson DM
    Cancer; 1977 Feb; 39(2):494-505. PubMed ID: 319891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumour immunity in malignant melanoma assay by tube leucocyte adherence inhibition.
    Marti JH; Thomson DM
    Br J Cancer; 1976 Aug; 34(2):116-33. PubMed ID: 962991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of leukocyte glass adherence and tube leukocyte adherence inhibition (LAI) reactivity by serum factors in dogs with progressing or spontaneously regressing canine transmissible venereal sarcoma (CTVS).
    Harding MW; Yang TJ
    Cancer Immunol Immunother; 1985; 19(3):168-76. PubMed ID: 3891077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A leukocyte adherence inhibition (LAI) assay of anti-tumor immunity in rats using selective radioimmunological assessment of adherence of T lymphocytes and monocytes.
    Morizane T; Sjögren HO
    Int J Cancer; 1983 Jun; 31(6):803-12. PubMed ID: 6345408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte adherence inhibition to myelin basic protein by cancer patients' T-lymphocytes in association with class II major histocompatibility antigens on monocytes.
    Thomson DM; Halliday WJ; Phelan K
    J Natl Cancer Inst; 1985 Dec; 75(6):995-1003. PubMed ID: 2415744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmembrane signal defect and absence of cancer extract induced leukocyte adherence inhibition (LAI) for leukocytes from patients with advanced cancer.
    Shenouda G; Thomson DM
    Cancer Immunol Immunother; 1984; 18(1):59-68. PubMed ID: 6333270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of anti-tumour cell mediated immunity and serum blocking factors in cancer patients by the leucocyte adherence inhibition test.
    Halliday WJ; Maluish A; Isbister WH
    Br J Cancer; 1974 Jan; 29(1):31-5. PubMed ID: 4820944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of leucocyte migration inhibition by breast tumour cell fractions.
    Jones BM
    Br J Cancer; 1976 Jul; 34(1):14-9. PubMed ID: 952712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes.
    Grosser N; Thomson DM
    Cancer Res; 1975 Sep; 35(9):2571-9. PubMed ID: 1097110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-reactive cells to tumor antigens in normal and tumor patients.
    Falk RE; MacGregor AB
    J Surg Res; 1976 Mar; 20(3):247-53. PubMed ID: 772313
    [No Abstract]   [Full Text] [Related]  

  • 14. Leukocyte adherence inhibition and specific immunoreactivity in malignant melanoma.
    Halliday WJ; Maluish AE; Little JH; Davis NC
    Int J Cancer; 1975 Oct; 16(4):645-58. PubMed ID: 51836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of different states of immunity to colon cancer in rats by a leukocyte adherence inhibition (LAI) assay assessing the adherence of T lymphocytes and monocytes selectively.
    Morizane T; Sjögren HO
    Int J Cancer; 1983 Jun; 31(6):813-6. PubMed ID: 6345409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological mechanisms of tube leukocyte adherence inhibition.
    Thomson DM; Grosser N
    Cancer Res; 1979 Feb; 39(2 Pt 2):576-81. PubMed ID: 83912
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunity to tumor-associated antigens in vasectomized men.
    Anderson DJ; Alexander NJ; Fulgham DL; Vandenbark AA; Burger DR
    J Natl Cancer Inst; 1982 Sep; 69(3):551-5. PubMed ID: 6180209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tube leukocyte adherence inhibition (LAI) assay in gastrointestinal (GIT) cancer.
    Tataryn DN; MacFarlane JK; Murray D; Thomson DM
    Cancer; 1979 Mar; 43(3):898-912. PubMed ID: 371789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of false positive and negative responses in the tube leucocyte adherence inhibition (tube LAI) assay.
    O'Connor R; MacFarlane JK; Murray D; Thomson DM
    Br J Cancer; 1978 Dec; 38(6):674-84. PubMed ID: 369586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Armed human monocytes challenged with a sensitizing cancer extract release substances pharmacologically similar to leukotrienes.
    Thomson DM; Phelan K; Morton DG; Bach MK
    Int J Cancer; 1982 Sep; 30(3):299-306. PubMed ID: 7129679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.